Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Envision Pharma Group and Alucio Partner to Power Next-Generation Scientific Exchange for the Life Science Industry

Envision Pharma Group (Envision) and Alucio announced a global partnership to power impactful, scientific exchange and deliver additional value for life science customers.

By combining Alucio’s innovative Beacon scientific exchange platform and technology with Envision’s extensive medical affairs experience and scientific content development expertise, a broader set of life science companies will have the ability to assemble, refine, and adapt their scientific content with ease. Beacon is a modern content activation and healthcare professional engagement platform built specifically for medical science liaisons, medical affairs professionals, and market access teams.

Recommended AI News: Crescent Bank Partners with Informed.IQ To Simplify the Lending Process for its Auto Dealers

Through this collaboration, Envision will provide strategic, insight-driven communications expertise with agile content development approaches to assist medical affairs and market access teams in taking full advantage of the Beacon platform and future Alucio technology products.

More broadly, this global partnership has the potential to transform current industry standards in stakeholder engagement by redefining best practice content development processes and leveraging technology to create powerful, personalized scientific exchanges. Through a user-centric approach, the companies will seek to enhance and integrate technology solutions that deliver real-time data and analytics to inform strategy and aid customer decision-making.

Related Posts
1 of 31,671

Recommended AI News: Leavened Announces New ConfigAI Feature

“Envision is a recognized, global leader within the medical affairs space. We are very excited about the potential of this partnership to bring the benefits of our modern scientific exchange platform to an even broader network and establish best practice in the context of content development, deployment, and engagement,” said Dave Gulezian, Alucio Co-Founder and Chief Executive Officer. “We also look forward to collaborating to identify new opportunities to address emerging customer needs.”

Envision’s Chief Executive Officer, Meg Heim, added, “We have been impressed with what Alucio has built with Beacon and the momentum they have generated within the medical affairs space. We’re equally excited to align our medical strategy, agile content development, and communications expertise with Alucio’s technology capabilities to further enhance our customers’ stakeholder engagement through a personalized, omni-channel approach.”

Recommended AI News: Marquee Dental Partners and HealthEM.AI Team up to Drive Reimagined Dental Care Experience

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.